A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: A department of defense prostate cancer clinical trials consortium study

2017 ◽  
Vol 35 (4) ◽  
pp. 149.e7-149.e13 ◽  
Author(s):  
Rahul Aggarwal ◽  
Alan Bryce ◽  
Charles J. Ryan ◽  
Andrea Harzstark ◽  
Christina Derleth ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Trials ◽  
Phase I ◽  
Department Of Defense ◽  
Phase I Study ◽  
Cancer Clinical Trials ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant ◽  
Multicenter Phase

A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e16060-e16060
Author(s):  
Rahul Raj Aggarwal ◽  
Vivian K. Weinberg ◽  
Charles J. Ryan ◽  
Andrea Lynne Harzstark ◽  
Alan Haruo Bryce ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant ◽  
Multicenter Phase

scholarly journals A Phase I Study of Everolimus and Docetaxel in Patients With Castration-Resistant Prostate Cancer

2015 ◽  
Vol 13 (2) ◽  
pp. 113-123 ◽  
Author(s):  
Kevin D. Courtney ◽  
Judith B. Manola ◽  
Aymen A. Elfiky ◽  
Robert Ross ◽  
William K. Oh ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant

scholarly journals Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration‐Resistant Prostate Cancer

2016 ◽  
Vol 21 (5) ◽  
pp. 535 ◽  
Author(s):  
Neeraj Agarwal ◽  
Jean‐Pascal Machiels ◽  
Cristina Suárez ◽  
Nancy Lewis ◽  
Michaela Higgins ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Receptor Antagonist ◽  
Phase I Study ◽  
Prolactin Receptor ◽  
Metastatic Breast ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant

scholarly journals Phase I Study of Seviteronel, a Selective CYP17 Lyase and Androgen Receptor Inhibitor, in Men with Castration-Resistant Prostate Cancer

2018 ◽  
Vol 24 (21) ◽  
pp. 5225-5232 ◽  
Author(s):  
Shilpa Gupta ◽  
Luke T. Nordquist ◽  
Mark T. Fleming ◽  
William R. Berry ◽  
Jingsong Zhang ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Phase I ◽  
Phase I Study ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant ◽  
Receptor Inhibitor

scholarly journals Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer

PLoS ONE ◽  
2018 ◽  
Vol 13 (8) ◽  
pp. e0202709
Author(s):  
Michael T. Schweizer ◽  
Kathleen Haugk ◽  
Jožefa S. McKiernan ◽  
Roman Gulati ◽  
Heather H. Cheng ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant
Sign in / Sign up

Export Citation Format

Share Document